Exosome-Total-Isolation-Chip (ExoTIC) device for isolation of exosome-based biomarkers
US-11073511-B2 · Jul 27, 2021 · US
US11761952B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11761952-B2 |
| Application number | US-202117345968-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 11, 2021 |
| Priority date | Feb 1, 2016 |
| Publication date | Sep 19, 2023 |
| Grant date | Sep 19, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A device (“the ExoTIC device”) for the isolation of extracellular vesicles from an extracellular vesicle-containing sample in which the sample is flowed through a membrane in a flow chamber to capture and purify the extracellular vesicles on the membrane. The extracellular vesicles may be washed and collected and utilized in any one of a number of ways including, but not limited to, identifying biomarkers of a disease, identifying the presence of a biomarker in a patient to determine whether a patient has a disease, and therapeutically treating existing diseases by re-introducing the extracellular vesicles, potentially modified, back into a body.
Opening claim text (preview).
What is claimed is: 1. A device for isolation of extracellular vesicles from an extracellular vesicle-containing sample, the device comprising: a flow chamber having an inlet and an outlet which are placed in fluid communication with one another by the flow chamber; and a membrane disposed in the flow chamber such that a fluid flowing from the inlet to the outlet through the flow chamber must pass through the membrane, the membrane adapted to collect extracellular vesicles from an extracellular vesicle-containing sample thereon while permitting a remainder of the extracellular vesicle-containing sample to flow through to the outlet. 2. The device of claim 1 , wherein the extracellular vesicles are exosomes. 3. The device of claim 2 , further comprising at least one supportive backing layer between the membrane and the outlet. 4. The device of claim 3 , wherein the at least one supportive backing layer comprises a paper pad. 5. The device of claim 4 , wherein the at least one supportive backing layer further comprise a filter between the membrane and the paper pad. 6. The device of claim 5 , wherein the membrane has a porosity with an average pore diameter selected from the group of 30 nm, 50 nm, 80 nm, 100 nm, 200 nm, 1000 nm, and 5000 nm. 7. The device of claim 6 , wherein the filter has an average pore diameter of 200 nm. 8. The device of claim 2 , wherein the flow chamber is defined by a pair of opposing plates fastened together to secure the membrane in place therebetween, one of the pair of opposing plates providing the inlet and the other of pair of opposing plates providing the outlet. 9. The device of claim 8 , further comprising a pair of gaskets positioned between the plates in which the membrane is secured between the pair of gaskets. 10. A modular device for isolation of extracellular vesicles from an extracellular vesicle-containing sample, the modular device comprising several devices for extracellular vesicle isolation according to claim 1 in series with one another, connecting the outlet of one of the devices to the inlet of another one of the devices, in which each of the several devices for extracellular vesicle isolation has a membrane with a different porosity than at least some of the others. 11. The modular device of claim 10 , wherein the membranes of each of the several devices have decreasing average pore diameters from the inlet of a first device to the outlet of the last device.
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q) · CPC title
for testing the pathological state of an organism · CPC title
involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title
characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title
characterised by the means or forces applied to move the fluids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.